Bayer/GSK Levitra Has 16% Share Of New Scripts; Sales Reach $180 Mil. In 2003

The erectile dysfunction agent's sales are at the upper end of Bayer's guidance; the drug is expected to become profitable in 2005. Bayer is counting on strong sales from Levitra given Cipro's loss of exclusivity in June.